183 related articles for article (PubMed ID: 15094397)
1. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
Popiel HA; Nagai Y; Onodera O; Inui T; Fujikake N; Urade Y; Strittmatter WJ; Burke JR; Ichikawa A; Toda T
Biochem Biophys Res Commun; 2004 May; 317(4):1200-6. PubMed ID: 15094397
[TBL] [Abstract][Full Text] [Related]
2. A toxic monomeric conformer of the polyglutamine protein.
Nagai Y; Inui T; Popiel HA; Fujikake N; Hasegawa K; Urade Y; Goto Y; Naiki H; Toda T
Nat Struct Mol Biol; 2007 Apr; 14(4):332-40. PubMed ID: 17369839
[TBL] [Abstract][Full Text] [Related]
3. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
[TBL] [Abstract][Full Text] [Related]
4. Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch.
Okamoto Y; Nagai Y; Fujikake N; Akiko Popiel H; Yoshioka T; Toda T; Inui T
Biochem Biophys Res Commun; 2009 Jan; 378(3):634-9. PubMed ID: 19061859
[TBL] [Abstract][Full Text] [Related]
5. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine homopolymers having 8-45 residues form slablike beta-crystallite assemblies.
Sharma D; Shinchuk LM; Inouye H; Wetzel R; Kirschner DA
Proteins; 2005 Nov; 61(2):398-411. PubMed ID: 16114051
[TBL] [Abstract][Full Text] [Related]
7. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
[TBL] [Abstract][Full Text] [Related]
8. N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function.
Schiffer NW; Céraline J; Hartl FU; Broadley SA
Biol Chem; 2008 Dec; 389(12):1455-66. PubMed ID: 18844449
[TBL] [Abstract][Full Text] [Related]
9. The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model.
Li P; Huey-Tubman KE; Gao T; Li X; West AP; Bennett MJ; Bjorkman PJ
Nat Struct Mol Biol; 2007 May; 14(5):381-7. PubMed ID: 17450152
[TBL] [Abstract][Full Text] [Related]
10. Oligoproline effects on polyglutamine conformation and aggregation.
Bhattacharyya A; Thakur AK; Chellgren VM; Thiagarajan G; Williams AD; Chellgren BW; Creamer TP; Wetzel R
J Mol Biol; 2006 Jan; 355(3):524-35. PubMed ID: 16321399
[TBL] [Abstract][Full Text] [Related]
11. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila.
Liévens JC; Rival T; Iché M; Chneiweiss H; Birman S
Hum Mol Genet; 2005 Mar; 14(5):713-24. PubMed ID: 15677486
[TBL] [Abstract][Full Text] [Related]
12. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers.
Behrends C; Langer CA; Boteva R; Böttcher UM; Stemp MJ; Schaffar G; Rao BV; Giese A; Kretzschmar H; Siegers K; Hartl FU
Mol Cell; 2006 Sep; 23(6):887-97. PubMed ID: 16973440
[TBL] [Abstract][Full Text] [Related]
13. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
Saunders HM; Bottomley SP
Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
[TBL] [Abstract][Full Text] [Related]
14. The structural impact of a polyglutamine tract is location-dependent.
Robertson AL; Horne J; Ellisdon AM; Thomas B; Scanlon MJ; Bottomley SP
Biophys J; 2008 Dec; 95(12):5922-30. PubMed ID: 18849414
[TBL] [Abstract][Full Text] [Related]
15. HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.
Vos MJ; Zijlstra MP; Kanon B; van Waarde-Verhagen MA; Brunt ER; Oosterveld-Hut HM; Carra S; Sibon OC; Kampinga HH
Hum Mol Genet; 2010 Dec; 19(23):4677-93. PubMed ID: 20843828
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
Kubota H; Kitamura A; Nagata K
Methods; 2011 Mar; 53(3):267-74. PubMed ID: 21195182
[TBL] [Abstract][Full Text] [Related]
17. Amino acid sequence requirements of peptides that inhibit polyglutamine-protein aggregation and cell death.
Ren H; Nagai Y; Tucker T; Strittmatter WJ; Burke JR
Biochem Biophys Res Commun; 2001 Nov; 288(3):703-10. PubMed ID: 11676500
[TBL] [Abstract][Full Text] [Related]
18. Increased aggregation of polyleucine compared with that of polyglutamine in dentatorubral-pallidoluysian atrophy protein.
Suzuki Y; Jin C; Yazawa I
Neurosci Lett; 2013 Sep; 552():156-61. PubMed ID: 23933208
[TBL] [Abstract][Full Text] [Related]
19. Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis.
Nagai Y; Popiel HA
Curr Pharm Des; 2008; 14(30):3267-79. PubMed ID: 19075705
[TBL] [Abstract][Full Text] [Related]
20. Folding of polyglutamine chains.
Chopra M; Reddy AS; Abbott NL; de Pablo JJ
J Chem Phys; 2008 Oct; 129(13):135102. PubMed ID: 19045125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
